Detalles de la búsqueda
1.
Elevated Fab glycosylation of anti-hinge antibodies.
Scand J Rheumatol
; 52(1): 25-32, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34726124
2.
Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial.
Scand J Rheumatol
; 52(2): 129-136, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35234569
3.
Serum drug concentrations to optimize switching from adalimumab to etanercept in rheumatoid arthritis.
Scand J Rheumatol
; 48(4): 266-270, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31012365
4.
The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region.
Ann Rheum Dis
; 74(1): 311-4, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25342759
5.
Lower etanercept levels are associated with high disease activity in ankylosing spondylitis patients at 24 weeks of follow-up.
Ann Rheum Dis
; 74(10): 1825-9, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24812290
6.
A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides.
Ann Rheum Dis
; 74(3): e15, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24532677
7.
Patients non-responding to etanercept obtain lower etanercept concentrations compared with responding patients.
Ann Rheum Dis
; 71(1): 88-91, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21914626
8.
Venous and arterial thromboembolic events in adalimumab-treated patients with antiadalimumab antibodies: a case series and cohort study.
Arthritis Rheum
; 63(4): 877-83, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21452312
9.
Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate?
Mult Scler Relat Disord
; 57: 103416, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34847379
10.
Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusion cycle: an open-label pharmacokinetic cohort study.
BMC Musculoskelet Disord
; 12: 12, 2011 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-21232150
11.
Spinning straw into gold: description of a disruptive rheumatology research platform inspired by the COVID-19 pandemic.
Arthritis Res Ther
; 23(1): 207, 2021 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34348783
12.
Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs.
Ann Rheum Dis
; 74(2): 474-5, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25433018
13.
Response to: 'The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region' by Rinaudo-Gaujous et al.
Ann Rheum Dis
; 74(8): e41, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25854585
14.
Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis.
Ann Rheum Dis
; 69(7): 1378-82, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19919943
15.
Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis.
Ann Rheum Dis
; 69(2): 409-12, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19596693
16.
Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study.
Ann Rheum Dis
; 69(5): 817-21, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19581278
17.
Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study.
Ann Rheum Dis
; 69(3): 490-4, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19363023
18.
The correlation of clinical efficacy, serum trough levels and antidrug antibodies in ustekinumab-treated patients with psoriasis in a clinical-practice setting.
Br J Dermatol
; 173(3): 855-7, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25865153
19.
The formation of autoantibodies and antibodies to TNF-α blocking agents in relation to clinical response in patients with ankylosing spondylitis.
Clin Exp Rheumatol
; 28(5): 661-8, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20822711
20.
Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis.
Ann Rheum Dis
; 68(4): 558-63, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18445623